MYOD1 and breast cancer: Sahu et al. showed that FBXO32 mediates K63 ubiquitination of CtBP1 to promote EMT in breast cancer [11], while Tanaka et al. found that FBXO32 inhibited the EMT in bladder epithelial carcinoma by targeting the degradation of MyoD [12].